North Star Investment Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

North Star Investment Management’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-315	Closed	-$66	–	1310
2023 Q2	$66	Hold	315	–	–	﹤0.01%	1275
2023 Q1	$50	Hold	315	–	–	﹤0.01%	1289
2022 Q4	$175	Hold	315	–	–	﹤0.01%	1283
2022 Q3	$0	Hold	315	–	–	﹤0.01%	1192
2022 Q2	$0	Hold	315	–	–	﹤0.01%	1194
2022 Q1	$0	Hold	315	–	–	﹤0.01%	1231
2021 Q4	$1K	Hold	315	–	–	﹤0.01%	1163
2021 Q3	$1K	Hold	315	–	–	﹤0.01%	1110
2021 Q2	$1K	Hold	315	–	–	﹤0.01%	1081
2021 Q1	$1K	Hold	315	–	–	﹤0.01%	1040
2020 Q4	$1K	Buy	+315	New	+$519	﹤0.01%	1012

Other funds holding INFI

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

North Star Investment Management's INFI Position: Q3 2023 in Review

North Star Investment Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 315 shares — an estimated $66 sold.

North Star Investment Management first reported a position in INFI in Q4 2020 and held it in 11 quarters. The position peaked at $1K in Q4 2021. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.

North Star Investment Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
North Star Investment Management sold 315 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $66.
North Star Investment Management first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2020 and held it in 11 quarters.
North Star Investment Management's Infinity Pharmaceuticals, Inc. position peaked at $1K in Q4 2021.
3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.

Based on North Star Investment Management's 13F filing for Q3 2023, filed 6 Nov 2023.